
UK invests in $12.5-million Stem-Cell Institute
The UK is to invest £8 million ($12.5 million) in a new center that will be dedicated to stem-cell biology and medicine, with the aim of developing new therapeutic approaches to illnesses that currently have no effective treatments.
The UK is to invest £8 million ($12.5 million) in a new center that will be dedicated to stem-cell biology and medicine, with the aim of developing new therapeutic approaches to illnesses that currently have no effective treatments. The funding will come from the UK’s Medical Research Council and the Wellcome Trust, two of the country’s largest funders of medical research.
According to a
“Our aim is to close the knowledge gap and to drive stem-cell research towards clinical applications,” Austin Smith, the director of the institute, said in the statement. “The world-class facilities will attract the best international talent from the fields of stem-cell biology and regenerative medicine to pursue this goal.”
An 8000 square meter facility is being purpose-built for the institute on the University of Cambridge’s Biomedical Research Campus. The location, close to one of Europe’s largest biotechnology clusters, will provide ample opportunity for industry collaboration.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.